Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 64 Colorectal Neoplasms 58 Rectal Neoplasms 46 Stomach Neoplasms 44 Neoplasm Metastasis 16 Pancreatic Neoplasms 15 Colonic Neoplasms 13 Triple Negative Breast Neoplasms 11 Neoplasms 11 Esophageal Neoplasms 9 Nasopharyngeal Carcinoma 8 Locally Advanced Rectal Cancer 7 Esophageal Squamous Cell Carcinoma 7 Cholangiocarcinoma 6 Biliary Tract Neoplasms 6 Carcinoma, Hepatocellular 5 HER2 Positive Metastatic Breast Cancer 4 Colorectal Cancer Metastatic 4 Adenocarcinoma 4 Solid Tumor 3 Recurrence 3 Gallbladder Neoplasms 3 Anus Neoplasms 3 Advanced Breast Cancer 3 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Neuroendocrine Tumors 2 Locally Advanced Colon Cancer 2 Hyperthermia 2 Head and Neck Neoplasms 2

Interventions

dehydroftorafur 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Platinum 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 Capecitabine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Anal Canal Carcinoma × Capecitabine × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡